| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2008 | US20080075776 Topical Pharmaceutical Compositions Containing An Antiacne Compound And Antibiotic Compound |
| 03/27/2008 | US20080075774 Treatment and/or prevention of a condition major depressive disorder and nicotine addiction; fewer incidences of and/or reduced severity of seizures associated with the administration of bupropion, as compared to known bupropion compositions |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |
| 03/27/2008 | US20080075772 Trisecting, quadrisecting, and a pentasecting score pattern in or on a tablet; psychotherapeutic doxepin hydrochloride; enhanced dosage flexibility |
| 03/27/2008 | US20080075771 Opioid antagonist is released in an amount that reduces effectiveness of opioid when dosage form is crushed; monolithic solidified oral dosage form; hydrophilic polymer such as alkyl cellulose or (meth)acrylic acid (co)polymer; drug delivery; resistant to dissolution in aqueous solutions of ethanol |
| 03/27/2008 | US20080075770 Monolithic solidified oral dosage form comprising a drug such as an opioid and a hydrophilic polymer such as alkyl cellulose or (meth)acrylic acid (co)polymer; dissolution resistant in aqueous solutions of ethanol; drug delivery |
| 03/27/2008 | US20080075769 Psychostimulant containing pharmaceutical composition |
| 03/27/2008 | US20080075767 Ibuprofen-containing liquid filled hard capsules |
| 03/27/2008 | US20080075764 Synthetic and semi-synthetic three-dimensional bodies, such as liposomes, which antiinflammatory, organ protective and immune regulatory effects; autoimmune diseases |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/27/2008 | US20080075762 Compositions for delivery of drug combinations |
| 03/27/2008 | US20080075758 Non-Antibiotic Intervention of Chlamydial Infection |
| 03/27/2008 | US20080075757 Dispersions of microemulsions in hydrogels for drug delivery |
| 03/27/2008 | US20080075756 Enhancing regeneration of lens cells in mammals after endocapsular extraction by filling a lens capsule bag with an injectable material comprising acrylated polysiloxane; intraocular lenses; cataracts, vision defects; coating lense with viscoelastic hyaluronic acid, cellulose, and/or collagen |
| 03/27/2008 | US20080075749 Methods and Compositions for Tissue Augmentation |
| 03/27/2008 | US20080075748 Cleansing articles for skin or hair |
| 03/27/2008 | US20080075747 Acidic oil in water emulsion comprising allantoin; emulsifier system of an acidic anionic polylmer such as carbopol and an ethoxylated ether or an ethoxylated ester; cosmetics; storage stability; can further include a carbohydrate polymer that can be polygalactose or polyarabinose |
| 03/27/2008 | US20080075745 Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075735 Demethylated and/or oxidized membrane DNA |
| 03/27/2008 | US20080075730 Methods and compositions for treating biofilms |
| 03/27/2008 | US20080075728 Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation |
| 03/27/2008 | US20080075725 Novel Immunointeractive Molecules and uses Thereof |
| 03/27/2008 | US20080075722 detecting the presence of a protein marker in patient sample, using a reagent which specifically binds with protein; comparing the copy number of a minimal common region; anticarcinogenic biodrugs |
| 03/27/2008 | US20080075719 Method for Augmenting B Cell Depletion |
| 03/27/2008 | US20080075718 biodegradable oligomers or polymers used for the controlled, localized and sustained delivery of drugs |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075710 Herbal composition for treating hangovers |
| 03/27/2008 | US20080075696 Treatment Of Hepatitis C In The Asian Population With Interferon-Beta |
| 03/27/2008 | US20080075694 kits containing genetic engineered modified vaccinia virus ankara (MVA), which carries a nucleotide sequence that codes for a fusion protein, used for enhancing T cell responses in mammals |
| 03/27/2008 | US20080075692 prophylaxis of blood disorder such as sickle cell anemia, beta -thalassemia, neutropenia or thrombocytopenia, comprising administering carboxylic acids, that stimulates production of fetal hemoglobin, hematopoiesis, erythropoiesis, myelopoiesis and neutrophil production |
| 03/27/2008 | US20080075691 Permucosal Composition and Method of Improving Permucosal Absorption |
| 03/27/2008 | US20080075688 open-cell foams useful for sequestering lipophilic materials present in the intestines or stomach, and for reducing side effects of lipase inhibitors; treatment of diarrhea |
| 03/27/2008 | US20080075687 Ophthalmic compositions containing a synergistic combination of three polymers |
| 03/27/2008 | US20080075677 mixtures of cinnamic acid, carotenoids, vitamin E, and carriers, used in sunscreen agents |
| 03/27/2008 | US20080075672 Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| 03/27/2008 | US20080075671 applying curcumin to an upper third of a nasal cavity of mammals, wherein it is absorbed through a nasal mucosa and transported to the brain of the mammal; treatment of neurodegenrative diseases |
| 03/27/2008 | US20080075670 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus |
| 03/27/2008 | US20080075667 Nanoparticles, nanocapsules and nanogels |
| 03/27/2008 | US20080075666 Methods and compositions for treating diastolic dysfunction |
| 03/27/2008 | US20080075664 Control Of Diabetes And Obesity |
| 03/27/2008 | US20080072640 Insecticidal Fertilizer Solids and Method of Preparation |
| 03/27/2008 | DE4216004B4 Verwendung kompetitiver Progesteronantagonisten Use of competitive progesterone antagonists |
| 03/27/2008 | DE112005003498T5 Herstellungsverfahren für Chinazolinderivate und Anwendung zur Herstellung zur Behandlung von Tumorerkrankungen A method for manufacturing and application for the production of quinazoline derivatives for the treatment of tumor diseases |
| 03/27/2008 | DE102006045803A1 Verwendung von Theanin zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von psychiatrischen Störungen des zentralen Nervensystems, insbesondere von Depressionen und Schmerzen Use of theanine for the preparation of a medicament for the prophylaxis and treatment of psychiatric disorders of the central nervous system, especially depression and pain |
| 03/27/2008 | DE102006045389A1 Topically acting dermatological humectant comprises hyaluronic acid and panthenol in the multilamellar layers of hydrogenated liposomes |
| 03/27/2008 | DE102006045097A1 Verwendungen von Cripowellinen und deren Derivate zur Behandlung von Tumorerkrankungen Uses of Cripowellinen and derivatives thereof for the treatment of tumor diseases |
| 03/27/2008 | DE102006044696A1 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung 3-cyano-5-thiazaheteroaryl-dihydropyridines and their use |
| 03/27/2008 | DE102006044694A1 Perorale feste Schmerzmittelzubereitung Peroral solid analgesic formulation |
| 03/27/2008 | DE102006043520A1 2-Phenoxynikotinsäure-Derivate und ihre Verwendung 2-Phenoxynikotinsäure derivatives and their use |
| 03/27/2008 | DE102006043519A1 4-Phenoxynikotinsäure-Derivate und ihre Verwendung 4-Phenoxynikotinsäure derivatives and their use |
| 03/27/2008 | DE102006043443A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 03/27/2008 | DE102006043245A1 Wound treating device with disinfectant and coagulant effects, for use in hemostatic materials such as dressings, contains chloramine-zeolite double layer system |
| 03/27/2008 | DE102006042436A1 Kaugummizubereitungen mit physiologischen Wirkstoffen Chewing gum compositions with physiologically active agents |
| 03/27/2008 | DE102006042143A1 Neue substituierte Bipyridin-Derivate und ihre Verwendung New substituted bipyridine derivatives and their use |
| 03/27/2008 | DE102006041905A1 Zubereitungen zur oralen Aufnahme (I) Preparations for oral ingestion (I) |
| 03/27/2008 | DE102006021874B4 4,5-Diphenyl-pyrimidinyl-amino substituierte Carbonsäuren, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, process for their preparation and their use as medicaments |
| 03/27/2008 | DE102005038632B4 Acyltryptophanole Acyltryptophanole |
| 03/27/2008 | CA2699184A1 Compositions and methods for ph targeted drug delivery |
| 03/27/2008 | CA2694294A1 Insecticidal composition comprising dill oil as potentiator for pyrethrin insecticides |
| 03/27/2008 | CA2691147A1 Prediction and prophylactic treatment of type 1 diabetes |
| 03/27/2008 | CA2666649A1 Insulin resistance improving agent |
| 03/27/2008 | CA2665851A1 Spiro benzazepines as vasopressin antagonists |
| 03/27/2008 | CA2665849A1 Spiro benzazepines used as vasopressin antagonists |
| 03/27/2008 | CA2664421A1 Hmg coa reductase mediated modulation of neurogenesis |
| 03/27/2008 | CA2664411A1 Platelet adp receptor inhibitors |
| 03/27/2008 | CA2664335A1 Rho kinase inhibitors |
| 03/27/2008 | CA2664247A1 Inhibitors of phosphodiesterase type-iv |
| 03/27/2008 | CA2664152A1 Serine hydrolase inhibitors |
| 03/27/2008 | CA2664130A1 Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 03/27/2008 | CA2664109A1 Use of compositions comprising l-theanine and epigallocatechin gallate in the treatment and prevention of cold and/or influenza |
| 03/27/2008 | CA2664099A1 Methods and compositions for treating amyotrophic lateral sclerosis (als) |
| 03/27/2008 | CA2664098A1 Compounds and method for treating canine cognitive dysfunction syndrome |
| 03/27/2008 | CA2664095A1 Glucopyranosyl-substituted difluorobenzyl-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture |
| 03/27/2008 | CA2664083A1 Combination of a glucocorticoid and a .beta.-cyclodextrin conjugated vitamin a derivate complex |
| 03/27/2008 | CA2664057A1 Azetidine derivatives as muscarinic receptor antagonists |
| 03/27/2008 | CA2664049A1 Novel method |
| 03/27/2008 | CA2663943A1 3-amino-pyridine derivatives for the treatment of metabolic disorders |
| 03/27/2008 | CA2663901A1 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 03/27/2008 | CA2663857A1 Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief |
| 03/27/2008 | CA2663795A1 Pulmonary surfactant formulations and methods for promoting mucus clearance |
| 03/27/2008 | CA2663791A1 Pyrazolo (1, 5-a) (1, 3, 5) triazine and pyrazolo (1, 5-a) pyrimidine derivatives useful as protein kinase inhibitors |
| 03/27/2008 | CA2663776A1 Rifaximin in an amorphous form |
| 03/27/2008 | CA2663737A1 Processes for the preparation of ciclesonide and its crystal form |
| 03/27/2008 | CA2663635A1 Novel genes related to glutaminyl cyclase |
| 03/27/2008 | CA2663599A1 Method for treating cancer harboring egfr mutations |
| 03/27/2008 | CA2663528A1 Heterocyclic inhibitors of c-met and uses thereof |
| 03/27/2008 | CA2663515A1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof |
| 03/27/2008 | CA2663347A1 Ppar mediated modulation of neurogenesis |
| 03/27/2008 | CA2663272A1 Composition for the treatment of amyotrophic lateral sclerosis |
| 03/27/2008 | CA2663269A1 Combination of nmda-receptor ligand and a compound with 5-ht6 receptor affinity |
| 03/27/2008 | CA2663263A1 Renin inhibitors |
| 03/27/2008 | CA2663242A1 Estratriene derivatives and their uses as 17beta-hydroxysteroid dehydrogenase inhibitors |
| 03/27/2008 | CA2663240A1 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | CA2662977A1 Method of optimizing the treatment of philadelphia-positive leukemia with abl tyrosine kinase inhibitors |
| 03/27/2008 | CA2662965A1 Use of lxr agonists for the treatment of osteoarthritis |
| 03/27/2008 | CA2662919A1 Pharmaceutical compositions containing rosuvastatin calcium |
| 03/27/2008 | CA2662848A1 2-aryl-6-phenylimidazo[1,2-.alpha.]pyridine derivatives, preparation thereof and therapeutic use thereof |
| 03/27/2008 | CA2662838A1 Oxindole derivatives |